TETRACYCLINE HCL

Tetracycline HCl is a more soluble salt form with identical antimicrobial activity. Side effects include nausea, dizziness, photosensitivity, and rare intracranial hypertension. Only GMP materials will be supplied, logistics all according to GDP.

SKU: a8f0c11ddee7 Category: Tag:

Product Description


Mechanism of Action

TETRACYCLINE HCL demonstrates a broad and highly integrated biochemical activity architecture involving multiaxis signalling interference, mitochondrial-network recalibration, catalyticdomain modulation, cytoskeletal restructuring, redoxequilibrium shaping, ionflux redistribution and transcriptionfactor pathway realignment. Its molecular geometry allows docking to catalytic residues, allosteric regulators, hydrophobic transmembrane helices, nucleotidebinding pockets, structural scaffolds and polymeric cytoskeletal networks. This enables TETRACYCLINE HCL to influence metabolic, structural, genomic, electrophysiological and stressadaptive systems simultaneously.

TETRACYCLINE HCL may modulate phosphorylation gradients, modify ERK/JNK/MAPK propagation speeds, influence PI3KAKT survival bias, shift Gprotein signalling states, control Ca²⁺ microdomain behaviour, alter IP/DAG cascades, and recalibrate cAMPPKA pathway amplitude. Mitochondrial impacts include ETCcomplex redistribution, ATP/ADP cycle reshaping, ROSthreshold displacement, membranepotential polarity changes and organellestress crosssignalling.

HighPrecision

  • Ultrascale kinome disruption & catalyticcascade modelling
  • Molecular docking & conformationalflow prediction
  • UPR/ERstress and mitophagy/autophagy integration research
  • Fullspectrum multiomics reconstruction (RNAseq, metabolomics, phosphoproteomics)
  • Advanced cytoskeletal forcedistribution & polymerturnover analysis
  • Cellfate simulation across apoptosis, ferroptosis, necroptosis & parthanatos
  • AIenhanced SAR/QSAR simulation for molecular optimisation

Toxicodynamics & Hazard Spectrum

  • Rapid ROS escalation & antioxidantbuffer collapse
  • Mitochondrial fragmentation or ETC suppression
  • Severe Ca²⁺/Na⁺/K⁺ ionflux destabilisation
  • Cytoskeletal polymer breakdown & structuralintegrity failure
  • Membrane rupture & lipidbilayer thinning
  • Overactivation of inflammatory cascades (NF-κB, STAT, IRF)
  • Activation of multiple programmed-cell-death pathways
  • Epigenetic drift including methylation instability

For expert not intended for biological exposure.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C22H25ClN2O8

Molecular Weight

480.9 g/mol

CAS Number

64-75-5

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, hydrochloride (1:1), (4S,4aS,5aS,6S,12aS)-; RefChem:476354; TETRACYCLINE HYDROCHLORIDE; 64-75-5; Tetracycline HCl

IUPAC/Chemical Name

(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride

InChl Key

YCIHPQHVWDULOY-FMZCEJRJSA-N

InChl Code

InChI=1S/C22H24N2O8.ClH/c1-21(31)8-5-4-6-11(25)12(8)16(26)13-9(21)7-10-15(24(2)3)17(27)14(20(23)30)19(29)22(10,32)18(13)28;/h4-6,9-10,15,25-26,29,31-32H,7H2,1-3H3,(H2,23,30);1H/t9-,10-,15-,21+,22-;/m0./s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/54704426;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download